Neoral conversion study: shift from Sandimmune classic formulation to Sandimmune Neoral in heart and lung transplant patients.
Heart Centre, Rigshospitalet, National University Hospital, Copenhagen, Denmark.
U
U
Svendsen
K
K
Larsen
H
H
Allermand
P
P
Thayssen
S
S
Jensen
G
G
Pettersson
D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation / Q000009:adverse effects / Q000379:methods* / Q000502:physiology; D016041:Heart-Lung Transplantation / Q000009:adverse effects / Q000379:methods / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D016040:Lung Transplantation / Q000009:adverse effects / Q000379:methods* / Q000502:physiology; D008875:Middle Aged; D012449:Safety
D007166:Immunosuppressive Agents; D016572:Cyclosporine